Skip to content

Neurocognitive measures as predictors for quit success in smokers

Neurocognitive measures as predictors for quit success in smokers - Prediction of quit success in smokers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37678
Enrollment
75
Registered
2012-03-01
Start date
2012-04-24
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine verslaving Smokers Tobacco addiction

Interventions

None listed

Sponsors

Erasmus Universiteit Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Signed informed consent 2) Age between 30 and 60 years 3) Smoking at least 15 cigarettes a day for smokers / not smoked more than 5 cigarettes lifetime for non smokers 4) Participants must be able to normally read from a computer screen.

Exclusion criteria

Exclusion criteria: 1) Epilepsy 2) History of gross neurological or psychiatric disorders 3) Regular use of addictive drugs other than nicotine 4) Use of Psychoactive medication except from medication to support giving up smoking

Design outcomes

Primary

MeasureTime frame
Main study parameters are quit success rates in smokers. ERP modulations representing error-processing, inhibitory control and smoking cue-reactivity will be used to predict quit success. The study will end when 75 smokers completed all study procedures.

Secondary

MeasureTime frame
- number of days before relapse - difference in the amount of smoking after the quit attempt relative to baseline measures - Age, gender and education - Craving scores before and after task performance - Baseline nicotine dependence levels - Use of psychoactive medication to support the quit attempt - Trait impulsivity measures - Mood states at moment of testing - Measures of alcohol use and recreational use of other drugs

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)